Compare Stocks → You’re invited: Biggest crypto event of 2024 (From InvestorPlace) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NASDAQ:BLUNYSE:MSB Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBLUBELLUS Health$14.74$14.62$6.38▼$14.76$1.87B0.193.08 million shs3.45 million shsMSBMesabi Trust$17.12-0.7%$17.95$16.68▼$26.00N/A0.839,319 shs25,739 shs7 Energy Stocks to Buy and Hold ForeverDo you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBLUBELLUS Health0.00%0.00%0.00%0.00%+2.08%MSBMesabi Trust-0.70%-1.67%-8.45%-17.33%-32.49%AI “wealth window” is closing soon! (Ad)Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.I put together this personal video [HERE]…MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBLUBELLUS Health0.009 of 5 stars0.00.00.00.00.63.30.0MSBMesabi Trust0.5025 of 5 stars0.03.01.70.01.40.01.3Analyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBLUBELLUS Health2.00HoldN/AN/AMSBMesabi TrustN/AN/AN/AN/ASales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBLUBELLUS Health$15K124,613.93N/AN/A$3.09 per share4.77MSBMesabi Trust$7.74MN/A$0.40 per share42.60$0.87 per shareN/AProfitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBLUBELLUS Health-$76.08M-$0.72N/AN/AN/A-578,586.63%-24.27%-23.14%N/AMSBMesabi Trust$5.31M$0.8619.91∞N/AN/A67.64%58.86%4/22/2024 (Estimated)DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBLUBELLUS HealthN/AN/AN/AN/AN/AMSBMesabi Trust$1.488.64%-40.60%172.09%1 YearsLatest MSB, BLU, CUV, and OXB DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date4/16/2024MSBMesabi Trustquarterly$0.298.3%4/29/20244/30/20245/20/2024(Data available from 1/1/2013 forward)DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBLUBELLUS HealthN/A33.4233.42MSBMesabi TrustN/A5.345.34OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBLUBELLUS Health90.37%MSBMesabi TrustN/AInsider OwnershipCompanyInsider OwnershipBLUBELLUS Health24.17%MSBMesabi Trust0.26%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableBLUBELLUS Health74126.81 million96.16 millionNot OptionableMSBMesabi TrustN/AN/AN/AOptionableMSB, BLU, CUV, and OXB HeadlinesSourceHeadlineMesabi Trust (MSB)finance.yahoo.com - April 16 at 2:19 AMMSBseekingalpha.com - April 7 at 12:10 AMMurray Stahl's Horizon Kinetics Reduces Stake in Mesabi Trustfinance.yahoo.com - February 7 at 7:42 AMMesabi Trust declares $0.37 dividendmsn.com - January 22 at 4:13 PMMesabi Trust Press Releasefinance.yahoo.com - January 22 at 4:13 PMMSB, HYMC and IAUX are among pre market gainersmsn.com - November 15 at 5:49 PMMesabi Trust Looks Attractive With Estimated Forward Yield Of 8.2% To 11.4%msn.com - October 18 at 2:57 PMMesabi Trust (MSB) Earnings Dates & Reportsinvesting.com - September 5 at 5:33 PMMesabi Trust plummets as Northshore not expected to fully open this yearmsn.com - April 26 at 10:23 AMMesabi Trust cancels April distributionbusinessnorth.com - April 16 at 11:56 PMMesabi Trust cancels distribution for Aprilmsn.com - April 14 at 8:58 PMStock Index Futures Move Lower as Investors Cautiously Await U.S. Big Bank Earnings, Retail Sales Datatheglobeandmail.com - April 14 at 10:57 AMOperating Issues And Recession Pricing Next: Avoid Mesabi Trustseekingalpha.com - January 31 at 1:49 AMPre-Market Brief: Stocks Mostly Lower as Economic Outlook Darkens, BoJ Policy Shifttheglobeandmail.com - December 20 at 6:11 AM7 Commodity Plays Set to Surgethestreet.com - December 18 at 10:05 AMPre-Market Brief: Stocks Retreat As Recession Fears Weigh On Sentimenttheglobeandmail.com - December 16 at 6:46 AMMesabi Trust (MSB) Stock Historical Prices & Data - Yahoo Financefinance.yahoo.com - November 12 at 5:09 PMMesabi Trust: Short-Term This Doesn't Look Great, Long-Term I Likeseekingalpha.com - November 5 at 3:05 PMMesabi Trust suspends distributionbusinessnorth.com - October 17 at 4:44 PMmsb.c - Mesabi Trust | Stock Price & Latest News | Reutersreuters.com - October 8 at 2:46 PMStocks Mixed After U.S. CPI Shock Raises Fed Rate Riskstheglobeandmail.com - September 14 at 8:54 AMMesabi Trust Stock (NYSE:MSB), Analyst Ratings, Price Targets, Predictionsbenzinga.com - September 11 at 10:48 PMMesabi Trust(MSB)fool.com - September 9 at 8:03 AMHow Cleveland-Cliffs' CEO Pushed Mesabi Trust's Dividend Off A Cliffseekingalpha.com - August 3 at 12:52 PMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop Headlines3 Value Stocks Too Small For Buffett’s PortfolioMarch 28, 2024 12:16 PMView 3 Value Stocks Too Small For Buffett’s PortfolioFoot Locker Builds Up Another Head of Steam; Gains ImminentMarch 28, 2024 10:58 AMView Foot Locker Builds Up Another Head of Steam; Gains Imminent5 Stocks in the Current Bull Market with Upside to ComeApril 5, 2024 10:14 AMView 5 Stocks in the Current Bull Market with Upside to Come5 High Short Interest Stocks Getting Squeezed With Upside To GoApril 5, 2024 9:25 AMView 5 High Short Interest Stocks Getting Squeezed With Upside To GoComprehensive PepsiCo Stock AnalysisApril 18, 2024 12:05 PMView Comprehensive PepsiCo Stock AnalysisAll Headlines Company DescriptionsBELLUS HealthNASDAQ:BLUBELLUS Health Inc., a clinical-stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. BELLUS Health Inc. was incorporated in 1993 and is based in Laval, Canada. As of June 28, 2023, BELLUS Health Inc. operates as a subsidiary of GSK plc.Mesabi TrustNYSE:MSBMesabi Trust, a royalty trust, engages in iron ore mining business in the United States. The company was incorporated in 1961 and is based in New York, New York. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.